Pay in 4 interest-free payments of $6.29 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
Phase 5: 2.4mg weekly (week 17 onward) This is the maximum recommended dose from the clinical trials
Most people do not see significant weight loss during this phase
Understanding this pattern helps women interpret their results more accurately and avoid discouragement during phases when progress feels slower
Users describe an improved sense of wellbeing attributed also to secondary health indicators such as blood pressure, cholesterol levels, sleep apnea and skin conditions improving substantially alongside their significant drop in body mass index
Compliance Disclaimer This product is sold strictly for laboratory research and analytical purposes only
US$ 20.95
US$ 26.02
US$ 20.42
US$ 29.93
US$ 27.22
